The success of the mRNA vaccines for COVID-19 led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As these projects scale into clinical trials ...
The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...
Comfort Conditioning announced the expansion of its commercial service offerings to include process piping for supporting industrial and commercial facilities across North Texas. The addition of ...
The biopharmaceutical industry is expanding rapidly, driven by an increasing demand for complex biomedicines. Today, manufacturing biomolecules presents unique challenges, like cost pressure and ...
The successes seen in a number of clinical studies on viral vector-based gene therapies (AAV, retroviral, and lentiviral vectors) are well documented, with an ever-broadening pipeline of products ...
Challenges and Opportunities in Highly Potent Active Pharmaceutical Ingredient (HPAPI) Manufacturing
Highly potent active pharmaceutical ingredients (HPAPIs) are at the forefront of pharmaceutical manufacturing. They are particularly common in targeted therapies and personalized medicines. This is ...
Lifecore Biomedical, Inc. announced a new 10-year commercial manufacturing and supply agreement with one of its existing customers to support the development of a novel ophthalmic therapeutic. This ...
Audio Pixels Holdings Limited ( ($AU:AKP) ) has shared an update. Audio Pixels Holdings Limited has announced that its independent MEMS ...
The two companies have announced an agreement to collaboratively explore technical and process opportunities to optimise commercial production of TRISO nuclear fuel to supply Kairos Power's advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results